The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world characteristics of stages II-III NSCLC patients (pts) who initiate neoadjuvant chemo-immunotherapy (NACT-I) and do not undergo surgical resection.
 
Jair Bar
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb; Janssen Oncology; Medison; Merck Serono; MSD; Novartis; Pfizer; Roche; Takeda
Research Funding - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Immunai (Inst); MSD (Inst); Novartis (Inst); Oncohost (Inst); Pfizer (Inst); Roche (Inst); Takeda (Inst)
 
Giuseppe Maiocco
No Relationships to Disclose
 
Kaushal Parikh
Consulting or Advisory Role - AstraZeneca (Inst); MJH Life Sciences; Takeda Science Foundation (Inst)
 
Talia Shentzer Kutiel
Honoraria - Amgen; AstraZeneca; Pfizer; Roche
Travel, Accommodations, Expenses - Gilead Sciences; Roche
 
Walid Shalata
No Relationships to Disclose
 
Sivan Shamai
Research Funding - Roche (Inst)
 
Mor Moskovitz
Honoraria - AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Pfizer; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Janssen; MSD; Roche
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - Pfizer; Roche
 
Chul Kim
Consulting or Advisory Role - Bayer; Bicycle Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Janssen; Onviv; Pinetree; Regeneron; Sanofi; Takeda
Research Funding - AstraZeneca; Black Diamond Therapeutics; Boehringer Ingelheim; Daiichi Sankyo; Genentech/Roche; Gilead Sciences; Janssen; Lyell Immunopharma; Macrogenics; Novartis; ORIC Pharmaceuticals; Regeneron
 
Muskan Agarwal
No Relationships to Disclose
 
Alfredo Addeo
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca/MedImmune; Bristol Myers Squibb Foundation; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca/MedImmune; Lilly
Travel, Accommodations, Expenses - Roche; Takeda
 
Arianna Marinello
No Relationships to Disclose
 
Damien Urban
Honoraria - AstraZeneca; Bristol-Myers Squibb; J-C healthcare; Megapharm; Merck Sharp & Dohme; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; Medison; Merck Sharp & Dohme
 
Stanislav Bahlai
No Relationships to Disclose
 
Dina Laznik
Employment - jusidman cancer center, sheba medical center; S.I.S Shulov-Innovative Sciene Ltd
Research Funding - Merck (Inst); Roche (Inst)
 
Idan Tsadok
No Relationships to Disclose
 
Hadas Gantz Sorotsky
Honoraria - AstraZeneca; BMS; BMS; Janssen Oncology; Merck; MSD Oncology; Pfizer; ROCHE
Consulting or Advisory Role - AMGEN; AstraZeneca; AstraZeneca; BMS; Johnson & Johnson/Janssen
Research Funding - MSD
Travel, Accommodations, Expenses - BMS; Johnson & Johnson/Janssen; Pfizer; Regeneron